D
Abirami Seetharaman
Indian Institute of Technology Madras, Cancer Institute
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Breast Cancer Treatment Studies · PI3K/AKT/mTOR signaling in cancer · Melanoma and MAPK Pathways
Employment
-
Indian Institute of Technology Madras Project Research Scientist I2023 - Present
-
Cancer Institute RESEARCH FELLOW2016 - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Nanoarchaeosomes loaded with tumor antigens elicit antigen-presenting cell activation and T cell response for cervical cancer immunotherapy Save
- PAK1-mediated phosphorylation of ARGLU1 promotes tumorigenic potential of breast cancer Save
- PELP1 expression is associated with disease progression in inflammation-driven oral cancer Save
- Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Transcriptome Analysis of Human Pancreatic Stellate Cells Co-cultured With PAK1-Modulated Cells Revealed the Role of Cytokine Pathway in Tumor Microenvironment Save
- Charge-defect tuned PVDF based ternary biocompatible composite as skin touch actuated single electrode triboelectric nanogenerator for wireless healthcare monitoring Save
- Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics Save
- Elucidating shape-mediated drug carrier mechanics of hematite nanomaterials for breast cancer therapeutics Save
- Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources Save
- Quercetin-loaded nanoarchaeosomes for breast cancer therapy: a ROS mediated cell death mechanism Save
- Combination of IDO1high and CCL19low expression in the tumor tissue reduces survival in HPV positive cervical cancer Save
- Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer Save
- Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates foxp3+ cells in vitro Save
- Immunotherapy for cervical cancer: Can it do another lung cancer? Save